期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 136, 期 2, 页码 343-344出版社
BLACKWELL PUBLISHING
DOI: 10.1111/j.1365-2141.2006.06409.x
关键词
sickle cell disease; acute chest syndrome; secretory phospholipase A2; transfusion
类别
资金
- NCRR NIH HHS [RR01271] Funding Source: Medline
- NHLBI NIH HHS [HL20985] Funding Source: Medline
- NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P60HL020985] Funding Source: NIH RePORTER
Acute pulmonary injury is known as acute chest syndrome (ACS) in patients with sickle cell disease (SCD). Secretory phospholipase A(2) (sPLA(2)) was found to predict those at risk for ACS and a trial was designed to determine if red blood cell transfusion can be used to prevent ACS. Patients with an elevated sPLA(2) were randomised to either receive a single transfusion or standard care. Five of the eight patients (63%) randomised to standard care developed ACS versus none of the seven patients randomised to the transfusion arm (P = 0.026, Odds ratio = 23.6, 95% confidence interval 1, 557). This study suggests that transfusion may prevent ACS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据